GENE ONLINE|News &
Opinion
Blog

Lymphoma
Trials & Approvals Roche
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
Trials & Approvals B-cell Lymphoma
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Asia-Pacific Cell Therapy
AbClon, HK inno.N Collaborates to Take On Novartis’ CAR T-Cell Therapy
2022-02-15
China Cancer
Angel Pharma Pushes First-In-Class ITK Inhibitor into Trial in China
2021-10-27
Trials & Approvals Brukinsa
BeiGene Gets Its First Regulatory Nod in Australia for Rare Lymphoma
2021-10-08
Trials & Approvals
Roche Aspires for Dominance in DLBCL Market, Unveils Pivotal Trial Data for Polivy
2021-08-09
Trials & Approvals Lymphoma
TG Therapeutics Gets Conditional FDA Okay for its First Lymphoma Drug
2021-02-09
Policy
Taiwan Approves Six Cell Therapies Under Revised Guidelines
2018-09-13
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top